| Catalog No. |
Size |
Price |
Figures |
|---|
Z00147-1 mg
| 1 mg | $ 420.00 |
References:
- Eshima N, Tabata M et al. Population dynamics of HTLV-I infection: a discrete-time mathematical epidemic model approach. Math Med Biol. Mar 2003;20(1):29-45.
- Furukawa Y, Kubota R et al. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Blood. Feb 2001;97(4):987-93.
- Nath MD, Ruscetti FW et al. Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood. Apr 2003;101(8):3085-92.
|
|---|
| Full Name | | Human T-Lymphocyte Virus (HTLV)-1 Envelope |
|
| Abbreviated Name-1 | rHTLV-I |
|---|
| Abbreviated Name-2 | HTLVI envelope; HTLV-1 envelope; HTLV1 envelope |
|---|
| Description | GenScript Human T-Lymphocyte Virus (HTLV)-1 Envelope contains the C- terminus of gp46 and most of p21E of HTLV-I. This non-fusion, E. coli-derived protein starts from HIV-1 env. amino acid 165, and ends in amino acid 440. Human T-cell Leukaemia Virus Type I (HTLV-I) is a retrovirus that causes adult T-cell leukaemia (ATL). |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure (as determined by HPLC-C4, and 10% PAGE). |
|---|
| Storage | Store at -20°C. Keep container tightly closed. |
|---|
| Concentration | 1 mg/ml in 10 mM Na-PO4, pH 6.0, containing 0.1% SDS, and 1 mM DTT; final concentration: 1 mg per vial |
|---|
| Stability | The protein will remain stable for five years if stored frozen and for six months in solution if stored in solution at 4°C. |
|---|
| Specificity | This protein is immunoreactive with all sera of HTLV-I and HTLV-II infected individuals with antibody response to HTLV envelope. |
|---|
| Applications | Use this protein as an antigen in ELISA and western Blots. It makes an excellent reagent in the correct detection of HTLV infections. It shows minimal specificity problems. |
|---|
